These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7700404)

  • 1. [Antifibrinolytic therapy].
    Levi M; ten Cate JW
    Ned Tijdschr Geneeskd; 1995 Mar; 139(12):613-7. PubMed ID: 7700404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemostatic activity of certain antifibrinolytics in hemorrhagic diathesis mainly caused by thrombocytopenia].
    Gembitskiĭ EV; Larchenko GK
    Klin Med (Mosk); 1975 May; 53(5):58-65. PubMed ID: 1152391
    [No Abstract]   [Full Text] [Related]  

  • 3. Trasylol therapy of haemorrhage in surgical patients.
    Amris CJ
    Acta Chir Scand Suppl; 1967; 378():45-52. PubMed ID: 5300106
    [No Abstract]   [Full Text] [Related]  

  • 4. [Accompanying fibrinolysis in hematologic diseases and its modification by PAMBA].
    Mey U; Sundermann A; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):80-7. PubMed ID: 4173886
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute defibrination hemorrhage caused by stress fibrinolysis during surgery].
    Wille P
    Zentralbl Gynakol; 1968 Aug; 90(35):1177-81. PubMed ID: 5304675
    [No Abstract]   [Full Text] [Related]  

  • 6. Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid.
    Bergin JJ; Crosby WH; Jahnke EJ
    Mil Med; 1966 Apr; 131(4):340-4. PubMed ID: 4955920
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent trends in antifibrinolytic therapy.
    Menon IS
    Br J Clin Pract; 1967 Aug; 21(8):405-8. PubMed ID: 6076264
    [No Abstract]   [Full Text] [Related]  

  • 8. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.
    Niego B; Horvath A; Coughlin PB; Pugsley MK; Medcalf RL
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):322-4. PubMed ID: 18469556
    [No Abstract]   [Full Text] [Related]  

  • 9. [Substances inhibiting fibrinolysis].
    Lakin KM; Rachitskaia NG; Gavrilov AP
    Kardiologiia; 1972 Apr; 12(4):139-53. PubMed ID: 4558033
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinolytic and antifibrinolytic treatment].
    Sterkowicz S
    Wiad Lek; 1968 Jun; 21(12):1035-41. PubMed ID: 4875370
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of PAMBA in dentistry].
    Rothe G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):67-71. PubMed ID: 4173883
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of hemorrhagic syndromes. Part I].
    Ballerini G
    Clin Ter; 1974 Jul; 70(2):117-45. PubMed ID: 4409281
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protease inhibitors and antifibrinolytic therapy].
    Manrique R
    Arq Bras Cardiol; 1984 Nov; 43(5):355-60. PubMed ID: 6242229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemorrhagic diathesis in viral hepatitis and new therapeutic prospects (tranhexamic acid)].
    Grasso E
    Minerva Med; 1973 Oct; 64(69):3637-40. PubMed ID: 4775555
    [No Abstract]   [Full Text] [Related]  

  • 15. [Some hemocoagulative effects of antifibrinolytic therapy in the minor hemorrhagic diathesis of hepatic cirrhosis].
    Turpini R
    Minerva Gastroenterol; 1976; 22(2):153-8. PubMed ID: 972747
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathologic fibrinolysis as a cause of clinical bleeding.
    Stump DC; Taylor FB; Nesheim ME; Giles AR; Dzik WH; Bovill EG
    Semin Thromb Hemost; 1990 Jul; 16(3):260-73. PubMed ID: 2237447
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F
    Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412
    [No Abstract]   [Full Text] [Related]  

  • 18. Amicar and hyperfibrinolysis.
    Med Lett Drugs Ther; 1967 Jan; 9(3):10-1. PubMed ID: 6067964
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research on the pathogenetic mechanisms of hemorrhages due to induced venous stasis. II. Role of fibrinolysis in the pathogenesis of the hemorrhagic phenomenon due to stasis].
    Neri Serneri GG; Rossi Ferrini PL; Franchi F; Paoletti P
    Haematologica; 1965; 50(4):251-66. PubMed ID: 4953556
    [No Abstract]   [Full Text] [Related]  

  • 20. Basis of antifibrinolytic therapy.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():35-40. PubMed ID: 6159375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.